David M. Knott’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

David M. Knott’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-225,400	Closed	-$392K	–	110
2018 Q2	$392K	Hold	225,400	–	–	0.15%	71
2018 Q1	$412K	Buy	225,400 +24,000	+12%	+$50.7K	0.17%	65
2017 Q4	$449K	Buy	201,400 +43,000	+27%	+$107K	0.18%	65
2017 Q3	$459K	Hold	158,400	–	–	0.2%	61
2017 Q2	$705K	Hold	158,400	–	–	0.29%	40
2017 Q1	$738K	Hold	158,400	–	–	0.36%	28
2016 Q4	$965K	Hold	158,400	–	–	0.49%	20
2016 Q3	$873K	Hold	158,400	–	–	0.45%	21
2016 Q2	$602K	Hold	158,400	–	–	0.14%	43
2016 Q1	$437K	Buy	158,400 +5,500	+4%	+$19.9K	0.12%	49
2015 Q4	$867K	Buy	152,900 +8,800	+6%	+$53.6K	0.24%	39
2015 Q3	$764K	Buy	144,100 +74,100	+106%	+$573K	0.22%	39
2015 Q2	$581K	Buy	+70,000	New	+$339K	0.12%	49

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

David M. Knott's SGYP Position: Q3 2018 in Review

David M. Knott sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 225,400 shares — an estimated $392K sold.

David M. Knott first reported a position in SGYP in Q2 2015 and held it in 13 quarters. The position peaked at $965K in Q4 2016. 134 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

David M. Knott reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
David M. Knott sold 225,400 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $392K.
David M. Knott first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 13 quarters.
David M. Knott's Synergy Pharmaceuticals, Inc Common Stock position peaked at $965K in Q4 2016.
134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on David M. Knott's 13F filing for Q3 2018, filed 13 Nov 2018.